Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Affiliations

• ¹ Center for Hematologic Malignancies, Oregon Health and Science University, Knight Cancer Institute, Portland, OR, USA. meyersg@ohsu.edu.
• ² BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin and Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• ³ Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, and Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
• ⁴ Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical, Duarte, CA, USA.
• ⁵ Centre Hospitalier Universitaire de Nantes, Nantes, France.
• ⁶ Division of Hematology, The Ohio State University Comprehensive Cancer Center - The James, Columbus, OH, USA.
• ⁷ MSK Kids Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁸ Universitätsklinikum Regensburg, Regensburg, Germany.
• ⁹ Xenikos BV, Nijmegen, The Netherlands.
• ¹⁰ National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
• ¹¹ H. Lee Moffitt Cancer Center, Tampa, FL, USA.
• ¹² Division of Oncology, BMT and Leukemia Section, Washington University School of Medicine, St. Louis, MO, USA.
• ¹³ Universitätsklinikum Münster (UKM), Münster, Germany.
• ¹⁴ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
• ¹⁵ Universitair Medisch Centrum Groningen, Groningen, The Netherlands.
• ¹⁶ Hematology Department, CHU Lille, Lille, France.
• ¹⁷ Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France.
• ¹⁸ Center for Hematologic Malignancies, Oregon Health and Science University, Knight Cancer Institute, Portland, OR, USA.
• ¹⁹ Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Germany.
• ²⁰ The Emmes Company, Rockville, MD, USA.
• ²¹ Blood and Marrow Transplantation & Cellular Therapy Program, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
• ²² Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²³ Hematology Transplantation, Hospital St Louis and University Paris Cité, Paris, France.